Recent advancements in genetic engineering and biotechnology are dramatically reducing costs and improving the accuracy of gene editing techniques. This progress is making synthetic biology much more accessible and efficient than ever before.
“According to SNS Insider Research, The Synthetic Biology Market Size was valued at US$ 14.19 Billion in 2023 and is expected to reach US$ 65.61 Billion by 2032 and grow at a CAGR of 19.61% over the forecast period 2024-2032.”